Sinocare Inc. (SHE:300298)

Market Cap	11.02B
Revenue (ttm)	4.57B
Net Income (ttm)	309.46M
Shares Out	552.98M
EPS (ttm)	0.56
PE Ratio	35.62
Forward PE	26.46
Dividend	0.22 (1.10%)
Ex-Dividend Date	Jun 13, 2025

Volume	3,906,411
Average Volume	9,233,134
Open	19.98
Previous Close	19.94
Day's Range	19.88 - 19.99
52-Week Range	19.32 - 35.46
Beta	-0.29
RSI	37.21
Earnings Date	Oct 24, 2025

About Sinocare

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. Sinocare Inc. was founded in 2002 and is based in Changsha, the ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 4,809
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300298

Financial Performance

In 2024, Sinocare's revenue was 4.44 billion, an increase of 9.47% compared to the previous year's 4.06 billion. Earnings were 326.29 million, an increase of 14.73%.